Stocks and Investing
Stocks and Investing
Thu, November 30, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mike Matson Reiterated (ATRC) at Strong Buy and Held Target at $49 on, Nov 29th, 2023
Mike Matson of Needham, Reiterated "AtriCure, Inc." (ATRC) at Strong Buy and Held Target at $49 on, Nov 29th, 2023.
Mike has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 0 agree with Mike's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Mike
- Robbie Marcus of "JP Morgan" Maintained at Buy with Decreased Target to $50 on, Thursday, November 2nd, 2023
- Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $56 on, Friday, September 29th, 2023
Contributing Sources